Comparison of ultrasound-guided percutaneous radiofrequency ablation and reoperation for nerve-adjacent cervical lymph node recurrence of papillary thyroid carcinoma: a propensity score–matched study - Takeaways - MDSpire

Comparison of ultrasound-guided percutaneous radiofrequency ablation and reoperation for nerve-adjacent cervical lymph node recurrence of papillary thyroid carcinoma: a propensity score–matched study

  • By

  • Yuhan Xie

  • Yuhan Qiu

  • Lingpeng Tang

  • Ting Hu

  • Songsong Wu

  • Jianchuan Yang

  • June 11, 2026

  • 0 min

Share

  • 1

    Ultrasound-guided radiofrequency ablation (RFA) showed a mean volume reduction ratio of 0.97 at 24 months for recurrent papillary thyroid carcinoma.

  • 2

    RFA demonstrated significantly lower overall complication rates compared to surgical reoperation, particularly in nerve-related complications.

  • 3

    RFA resulted in shorter procedure times, reduced hospital stays, and smaller postoperative scars compared to reoperation.

  • 4

    The overall local recurrence rates were similar between RFA and reoperation groups, indicating comparable efficacy.

  • 5

    RFA may be a viable treatment option for patients with nerve-adjacent recurrent papillary thyroid carcinoma who cannot undergo reoperation.

Original Source(s)

Comparison of ultrasound-guided percutaneous radiofrequency ablation and reoperation for nerve-adjacent cervical lymph node recurrence of papillary thyroid carcinoma: a propensity score–matched study

  • by Yuhan Xie, Yuhan Qiu, Lingpeng Tang, Ting Hu, Songsong Wu, Jianchuan Yang

  • June 11, 2026

Related Content

Obesity-driven metabolic reprogramming and immune dysfunction in renal cancer

Latent transition analysis of resilience in breast cancer patients and its association with sense of meaning in life: a longitudinal follow - up study

Integrative single-cell and bulk transcriptomic analyses identify DRAM1 as a candidate gene from fibroblast-associated transcriptional programs in colorectal cancer